Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 1/20 | 0.55 |
| ▸ | FAP | Q12884 | 1/20 | 0.55 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.54 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 8/20 | 0.53 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.51 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 6/20 | 0.47 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2860724 | 0.95 | PREP (0.55) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL2860717 | 0.95 | TAS1R3 (0.58) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL2863465 | 0.93 | TAS1R3 (0.57) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL13702150 | 0.82 | FDPS (0.57) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL2859570 | 0.80 | PREP (0.50) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL2876496 | 0.78 | SMYD3 (0.53) | PREPIDO1CHRNA1CYP2C8CYP2C9 | |
| SCHEMBL2872305 | 0.77 | SMYD3 (0.52) | IDO1CYP2C9CYP2C19SMYD3MAPK1 | |
| SCHEMBL2863472 | 0.77 | TAS1R3 (0.57) | PREPFAPTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL2859820 | 0.76 | WDR5 (0.48) | TAS1R3TAS1R1CYP2C9CYP2C19 | |
| SCHEMBL2859345 | 0.76 | KCNK3 (0.51) | IDO1CYP2C9CYP2C19SMYD3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137376-A1 | AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100137376-A1 | AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100137376-A1 | AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2174931-A1 | AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137376-A1 | AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME | NAAA, NAT1, SAT1 | PREP 617/4885FAP 4212/4885TAS1R3 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.